Samsrita Labs Peer Comparison

BSE: 539267

₹13.20

₹0.24 (1.85%)

As on 23-Oct-2026 12:44IST

Market cap

₹31 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

P/B Ratio

2.7

Div. Yield

0 %

Edit

	Samsrita Labs	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Market cap (₹ Cr)	31	232	133	34	30
Revenue (₹ Cr)	0	57	26	17	24
Net Profit (₹ Cr)	-8.72	0.15	-0.45	1.93	-3.62
Net Margin (%)	-17,442.00	0.26	-1.72	10.69	-15.36
RoE (%)	-60.02	0.26	-3.41	5.30	--
Price to Earnings	--	1,545.86	--	17.40	--
Price-To-Book	2.71	3.82	10.89	0.99	-11.34

Income Statement (₹ Cr)

	Samsrita Labs	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Operating Revenue	0.02	53.71	22.00	16.55	29.84
Total Income	0.05	54.89	22.39	24.55	31.18
Total Expenditure	8.73	50.16	18.47	14.69	29.92
EBITDA	-8.71	3.55	3.52	1.86	-0.08
Depreciation	0.00	3.75	1.49	0.61	0.50
EBIT	-8.72	-0.20	2.03	1.25	-0.58
Interest	0.00	1.03	0.35	0.10	0.99
Other Income	0.03	1.18	0.39	8.00	1.35
Exceptional Items	--	0.00	--	--	--
Profit before Tax	-8.69	-0.05	2.02	9.14	-0.22
Provision for Tax	--	-0.13	--	1.40	-0.04
Profit after Tax	-8.69	0.08	2.02	7.74	-0.19

	Samsrita Labs	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Shareholder's Funds	11.75	60.14	12.17	38.52	1.30
Minority Interest	--	--	--	--	--
Non-Current Liabilities	0.09	12.92	2.92	0.66	10.49
Current Liabilities	2.54	9.34	2.37	2.44	10.38
Total Liabilities	14.38	82.60	17.46	41.62	22.17

	Samsrita Labs	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Non-Current Assets	11.84	71.03	12.10	37.58	8.39
Current Assets	2.54	11.37	5.36	4.04	13.78
Total Assets	14.38	82.60	17.46	41.62	22.17
Total Debt*	1.66	12.10	1.21	1.78	10.52
Net Current Assets	0.01	2.03	2.99	1.59	3.39
Contingent Liabilities	--	0.99	1.12	0.09	0.03

	Samsrita Labs	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Cash From Operating Activities	-4.26	3.02	1.83	1.81	1.47
Cash Flow from Investing Activities	3.26	-12.37	0.12	-1.23	-0.52
Cash from Financing Activities	2.63	9.03	-0.99	-0.62	-0.24
Net Cash Inflow / Outflow	1.63	-0.32	0.95	-0.03	0.71

	Samsrita Labs	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
ROCE (%)	-62.45	1.47	19.27	23.83	6.58
ROE (%)	-73.22	0.13	18.13	20.73	-12.79
ROA (%)	-58.00	0.11	12.57	18.98	-0.89
EBIT Margin (%)	-47,884.92	8.81	17.79	59.58	4.24
Net Margin (%)	-17,511.30	0.15	9.03	31.53	-0.60
Cash Profit Margin (%)	0.00	7.13	15.98	50.48	1.06

	Samsrita Labs	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Revenue Growth (%)	--	8.38	66.60	-1.99	9.48
EBIT Growth (%)	-3,282.58	-2.68	611.07	51.11	607.46
Net Profit Growth (%)	-3,247.46	-89.12	175.69	53.75	88.92
EPS Growth (%)	-1,765.31	-89.11	175.69	53.75	88.92
Book Value Growth (%)	-1.83	0.23	19.94	6.59	-19.64

	Samsrita Labs	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Price / Earnings	0.00	2,618.86	43.37	7.06	0.00
Price / Book Value	3.07	3.50	7.21	1.42	15.72
Dividend Yield (%)	0.00	0.00	0.00	2.15	0.00
EV/EBITDA	-4.16	46.31	22.18	5.48	22.85
Market Cap (₹ Cr)	36.08	210.77	87.73	54.63	20.42

	Samsrita Labs	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Debt to Equity	0.14	0.20	0.10	0.05	8.10
Short term debt to equity ratio	0.14	--	--	0.05	0.31
Current Ratio	1.00	1.22	2.26	1.65	1.33
Quick Ratio	1.00	0.81	2.05	1.56	1.24
Interest Coverage	-7,532.35	0.95	6.82	88.23	0.78

	Samsrita Labs	Lotus Eye Hosp	Aspira Pathlab	NG	Soni Medicare
Debtors to sales (%)	108.10	2.25	10.69	2.58	29.37
Asset Turnover	0.00	0.71	1.37	0.41	1.43
Receivable days	0.00	8.60	38.11	6.31	96.98
Inventory Days	0.00	26.04	7.95	15.24	8.69
Payable days	582.01	72.50	72.32	0.00	251.51
Cash Conversion Cycle	-582.01	-37.86	-26.26	21.54	-145.84

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.